Until mid-september, this medication taken: This article explores the topic in depth.
In addition,
Until mid-september. However, this medication taken:
In France, a drug prescribed against schizophrenia, depression or bipolar disorders could be missing until mid-September. For example, Authorities alert.
Patients under psychiatric treatment should be patient … Consequently, and vigilance. Furthermore, In August 2025. Furthermore, the National Medicines Safety Agency (ANSM) launched a new alert: supply tensions on Quétiapine, an active substance of Xeroquel and its generics, will last in the coming weeks.
In question, a delay in production of the Viatris laboratory, which further complicates an already fragile situation. “will lead to a deterioration in the availability of these treatments until mid-September 2025”specifies the ANSM. As alerted by Women’s Journalmore than 250. 000 French patients depend on this neuroleptic to treat bipolar disorders, severe forms of depression or schizophrenia.
© Shutterstock
Quétiapine stamps poured on a table.
Risks for patients – Until mid-september, this medication taken
The brutal interruption of this treatment can have heavy consequences: insomnia. anxiety, headache, but also a rapid psychiatric relapse. “Any disturbance in its availability can have significant repercussions on patient health”. Alerted Professor Antoine Pelissolo, head of the Créteil psychiatric service.
The problem only concerns prolonged release forms (LP) of 300 mg and 400 mg. Quétiapine 50 mg LP Viatris remains available. but the ANSM insists: “Do not postpone prescriptions and dispensations on Quétiapine LP 50 mg for patients not using this dosage usually”, Reported the Medspace.
What alternatives for treated patients?
Pharmacists have the possibility of preparing Quétiapine immediate Liberation capsules until mid-september, this medication taken (LI), following the official recommendations. This “masterful preparation” system allows you to adapt the doses with the available shapes (50, 100 or 150 mg). The authorities also validated an extension of their shelf life, now 12 weeks.
At the same time. the ANSM continues its research: “We are looking for alternative solutions with all laboratories marketing Quétiapine in France and Europe”. She also calls for a mobilization of stocks: “To the laboratories which can now release all of their stocks. in order to limit tensions, in the city as in the hospital, to the replenishment by the Viatris laboratory”.
function pixel_fb(){ !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,’script’,’//connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘410004889600609’); fbq(‘track’, “PageView”); }
Further reading: the French ill -informed in the face of a growing health threat – One in ten Israeli has been abusing sedatives since October 7, according to a study – Water is always unfit for consumption in Callas: the distribution of bottles continues – Urgentists use these 5 foods that hydrate 3 times better than heatwater – A single injection of gene therapy at birth can provide sustainable protection against HIV.
